The hemoglobinopathies refer to a diverse group of inherited disorders characterized by a reduced synthesis of one or more globin chains (thalassemias) or the synthesis of structurally abnormal hemoglobin (Hb). The thalassemias often coexist with a variety of structural Hb variants giving rise to complex genotypes and an extremely wide spectrum of clinical and hematological phenotypes. Hematological and biochemical investigations and family studies provide essential clues to the different interactions and are fundamental to DNA diagnostics of the Hb disorders. Although DNA diagnostics have made a major impact on our understanding and detection of the hemoglobinopathies, DNA mutation testing should never be considered a shortcut or the test of first choice in the workup of a hemoglobinopathy.
MATERIALS AND METHODS:
A careful three-tier approach involving: (1) Full blood count (2) Special hematological tests, followed by (3) DNA mutation analysis, provides the most effective way in which to detect primary gene mutations as well as gene-gene interactions that can influence the overall phenotype. With the exception of a few rare deletions and rearrangements, the molecular lesions causing hemoglobinopathies are all identifiable by PCR-based techniques. Furthermore, each at-risk ethnic group has its own combination of common Hb variants and thalassemia mutations. In Iran, there are many different forms of α and β thalassemia. Increasingly, different Hb variants are being detected and their effects per se or in combination with the thalassemias, provide additional diagnostic challenges. RESULTS: We did step-by-step diagnosis workup in 800 patients with hemoglobinopathies who referred to Research center of Thalassemia and Hemoglobinopathies in Shafa Hospital of Ahwaz Joundishapour University of medical sciences, respectively. We detected 173 patients as iron deficiency anemia (IDA) and 627 individuals as thalassemic patients by use of different indices. We have successfully detected 75% (472/627) of the β-thalassemia mutations by using amplification refractory mutation system (ARMS) technique and 19% (130/627) of the β-thalassemia mutations by using Gap-PCR technique and 6% (25/627) as Hb variants by Hb electrophoresis technique. We did prenatal diagnosis (PND) for 176 couples which had background of thalassemia in first pregnancy. Result of PND diagnosis in the first trimester was 35% (62/176) affected fetus with β-thalassemia major and sickle cell disease that led to termination of the pregnancy. CONCLUSION: Almost all hemoglobinopathies can be detected with the current PCR-based assays with the exception of a few rare deletions. However, the molecular diagnostic service is still under development to try and meet the demands of the population it serves. In the short term, the current generation of instruments such as the capillary electrophoresis systems, has greatly simplified DNA sequence analysis. The ancestral globin gene duplicated into α and β globin genes about 500 million years ago.
[10] Sub sequently, the α and β globin gene clusters have evolved by various duplication events and are now represented by two clusters 150 various known mutations, is even more perplexing.
[2]
Each population-at-risk, however, has its own spectrum of common mutations, usually from five to ten; a finding that simplifies mutation analysis and thus, determines the origin of the mutant genes. Thalassemia is found in some 60 countries with the highest prevalence in the Mediterranean region, parts of North and West Africa, the Middle East, the Indian subcontinent, southern Far
East and southeastern Asia, together composing the so [ Figure 1 ]. For the purpose of this review, the important globin genes in humans are the two β globin genes and the four α globin genes. Despite the different numbers of α and β globin genes, the net α/β globin protein output from these genes is balanced to give a ratio of 1.
[8]
Materials and Methods

Family studies
In view of the molecular heterogeneity found in the hemoglobinopathies, it is important to characterize each Mentzer Index, [11] England and Fraser Index, [12] Srivastava of the 627 patients (130 patients suspected to have Index, [13] Green and King Index, [14] Shine and Lal Index, [15] α-thalassemia and 472 patients suspected to have β red blood cell (RBC) count, red blood cell distribution thalassemia) were having thalassemia. Also, we detected width index (RDWI), [16] Mean Density of Hemoglobin per 23 individuals who had HbS, HbD panjub and two cases
Liter of blood (MDHL) and mean cell hemoglobin density were suspected to have Hb Lepore [ Table 2 ]. Later on the (MCHD). [17] If iron deficiency is present, it is essential to entire β globin gene was sequenced using direct mutation correct this and then repeat the full blood count and all analysis by nucleotide base sequencing to confi rm Hb other investigations. We detected 173 patients as IDA Lepore status. Finally, we found that for both cases the and the rest as thalassemia disorders. presences of Hb Lepore was ruled out.
Special hematological tests Sources of DNA
Once a hemoglobinopathy is suspected, the next tier of The main source of DNA is peripheral leucocytes investigation requires a number of special hematological obtained from blood anticoagulated, preferably with tests. These are often described as a "thalassemia ethylene diamine tetra acetic acid (EDTA). Fetal DNA screening". The tests are listed in Table 1 . We screened is mainly isolated from chorionic villi obtained through Noninvasive methods of prenatal diagnosis utilize DNA from fetal cells in maternal circulation [20] or free circulating fetal DNA in maternal blood.
[21] The noninvasive methods, however, are still under development and are not offered routinely for the hemoglobinopathies.
The third diagnostic tier involves DNA testing. This is requested in two circumstances: (1) a hemoglobinopathy cannot be confi rmed by the special hematological tests. Almost all the methods for DNA analysis of the repertoire chosen by a laboratory for molecular diagnosis hemoglobinopathies used today are based on the of the hemoglobinopathies depends on the spectrum of polymerase chain reaction (PCR). [23] Therefore whether mutations encountered in their catchment area and the a mutation is a deletion, a rearrangement or a point technical expertise available in the diagnostic laboratory.
mutation, a similar test will be performed with the It is good practice for any DNA diagnostic laboratory to variability and specificity coming from the primers have at least two alternative methods for detecting each used. The sensitivity and specificity of PCR has mutation.
revolutionized the molecular diagnostic field. It has almost eliminated the use of radioactive isotopes for detecting Direct sequence analysis sequences and has enabled diagnosis to be made For the β globin gene, which is relatively small (covering on much smaller quantities of DNA. The PCR-based 1.6 kb of genomic DNA including 5' and 3' untranslated techniques used in hemoglobin diagnostics include region), the majority of mutations can be detected in two allele-specific oligonucleotide (ASO) hybridization or sequence reads, whereas for α globin, each gene (α1 dot-blot analysis, reverse dot-blot analysis, allele-specifi c or α2) can be sequenced after specifi c amplifi cation in priming or amplification refractory mutation system a single read. This allows detection and identifi cation of 
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Although sequence analysis software is available it is not 100% efficient at detecting heterozygotes. This is an important consequence for the hemoglobinopathies as most cases involve carrier testing, therefore sequence traces frequently require checking by eye.
Allele-specific priming -ARMS-PCR
Primer-specifi c amplification is based on the principle that a perfectly matched primer is much more effi cient an internal PCR control which amplifies another region of the genome should be included in the reaction. The
ARMS-PCR has the advantage that it is theoretically
possible to detect any known mutation. [26] Recently, the methodology has been improved by development of a single tube assay, [28] where both the mutant and the wild type alleles are detected simultaneously in the same reaction with an internal positive control, referred to as tetra primer ARMS-PCR. We analyzed all 472 patients at annealing and directing primer extension than a who were suspected of having β-thalassemia by direct mismatched primer.The most widely used method is the mutation analysis of β-globin gene by ARMS and found ARMS, [26, 27] in which allele-specifi c amplification relies on the type of mutation of 385 of them, which are listed in the specificity of the 3' terminal nucleotide. To enhance Table 3 . We couldn't detect the mutation of the remaining allele specificity, it is common practice to deliberately 87 patients by this technique, which means the technique incorporate a second mismatch at position -2 or -3 from helped to detect approximately 75% (472/627) of the the 3' end. The target DNA is amplified in two separate mutations. The most predominant mutation that we have reactions using a common forward primer and either one found was IVS II -1 (G → C) (20%) followed by other of two reverse allele-specific primers, one complementary many less frequent known mutations for the Southern to the mutant sequence, the other to the normal DNA part of Iran, listed in Table 4. sequence. Presence of the mutant allele will generate a PCR product in the tube containing the mutation-specifi c
Gap-PCR
primer and vice versa. To monitor false-negative results because of failure of the amplification reaction itself, The PCR primer pairs are designed to flank a known involving one or both of the α-globin genes. [34] A small areas. [31, 35] The multiplex set encompassing gap-PCR deletion generating a unique amplicon that will be primers for /--SEA ,/-- smaller in the mutant sequence compared with the wild used by many laboratories supplemented by another set type. [29] For small deletions such as the 619bp deletion, for identification of triple α complex (/ααα) [32, 36] useful in a common cause of β-thalassemia in Asian Indians, the workup of thalassemia intermedia. Gap-PCR primers differential amplification products are generated in the are also available for the Thai α° deletion (/--THAI ) and mutant and wild type. When the deletion is vast (>2 kb) it can be included in the multiplex panels. [35] Multiplex gapis technically difficult to generate a product in the wild type. PCR requires careful optimization but once optimized, As a control, a primer can be included that anneals within is highly efficient and rapid for the detection of these the deleted sequence to generate an additional product common α° and α + -thalassemia deletions, particularly with one of the other primers flanking the deletion. In this when performed in large batches in microtitre plates. for the common HPFH and δβ-thalassemias. [30] Unlike the β-thalassemias, deletions are a common cause of α-thalassemia. The common α-thalassemia deletions and rearrangements can be routinely detected using gap-PCR. [31] [32] [33] Gap-PCR is also routinely used to detect Hb Lepore, a variant created by deletion of 7 kb and results in a functional hybrid delta/beta globin product.
[7]
In contrast to β-thalassemia, in which mutations are predominantly caused by point mutations in the structural genes, α-thalassemia is more often caused by deletions study. So for confirming that we analyzed the α-globin Table 5 .
Restriction enzyme analysis of PCR product
Restriction enzymes cut double-stranded DNA at specific recognition sequences; some mutations naturally create or abolish restriction enzyme sites. Computer Another useful specialized test helpful in confi rming a thalassemia and whether it is due to α or β globin gene problem is the α/β globin protein ratio. This requires the incubation of red blood cells with a radioactive tracer such as H 3 -leucine. [39] The peaks representing α and β globin The α/β globin protein ratio the technique is an invaluable molecular diagnostic tool. However, it is limited in its application as only a proportion of the hemoglobin variants, β-thalassemia and α-thalassemia mutations, naturally create or abolish restriction enzyme cutting sites. [35, 37] Incomplete or partial digests can be a problem for some restriction enzymes leading to false negative or positives -thus positive and negative controls should always be included. Restriction endonucleases are usually used when there is some other evidence suggesting the causative mutation, for some instances, although the mutations do not naturally create or abolish a restriction enzyme site, the sequence in the vicinity of the mutation allows one to artificially create restriction sites adjacent to the mutation sequence by introducing a single base mismatch in the amplifi cation primer. This technique, referred to as amplificationcreated restriction site (ACRS) is routinely used to identify the Saudi nondeletional alpha thalassemia mutation in the α2-globin gene, AATAAA to AATAAG. [38] We attempted to detect mutations from those individual who found as showed values more than 1.0 and were considered as α-thalassemia cases which was subsequently confi rmed as α-thalassemia heterozygous by molecular techniques [ Table 6 ].
Foetal DNA analysis Fakher, et al.: Methods and molecular diagnosis of hemoglobin disorders in Khuzestan 12 weeks). [40] Chorionic villus sampling provides a good yield of DNA which is isolated using conventional methods of phenol chloroform extraction after careful microscopic dissection to remove any contaminating maternal deciduas. Occasionally, if the sample is too small, it may need to be cultured increasing the risk of maternal contamination. Amniocytes obtained in the second trimester can also be used as a source of fetal DNA but the fetal cells are often contaminated with order to confirm maternal DNA contamination we used polymorphic DNA markers including the variable tandem repeats (VNTRs) in all cases [ Table 7 ]. In almost all of the cases they showed heterozygous patterns.
Conclusion
The compactness of the globin genes means that hemoglobinopathy detection is largely a PCR-based maternal cells and the results have to be interpreted with approach that can utilize direct sequencing analysis. caution after analysis for maternal contamination.
Almost all hemoglobinopathies can be detected with the Every prenatal diagnosis should be accompanied by current PCR-based assays with the exception of a few copies of hematology results of the parents and prior rare deletions. However, the molecular diagnostic service confirmation of the parental phenotypes and genotypes.
is still under development to try and meet the demands The PCR-based techniques that best suit the expertise of of the population it serves. A higher throughput approach the laboratory are then used to screen for the presence will be required to meet practice pressures and the of the parental mutations in the fetal DNA. Parental, increasing needs set by the antenatal screening program. appropriate positive and negative controls must always This increasing workload dictates increasing automation, be included in the investigations. A limited number of PCR which may necessitate the use of automated robotic cycles (25-28) should be performed to avoid amplifi cation platforms to prepare samples and reactions and the use of any minor DNA species and to minimize amplifi cation of of automated platforms to perform the actual detection. any contaminating maternal DNA. As an added precaution,
In most populations the β-thalassemias (and related maternal DNA contamination should be checked for by hemoglobinopathies) are clinically more relevant than the using polymorphic DNA markers including the variable β-thalassemias.The complex mutational spectrum of the tandem repeats (VNTRs) such as ApoB and the short hemoglobinopathies, especially relevant in a multi-ethnic tandem repeats or micro satellites. [41] This is particularly community, requires a method with the capacity to scan important when the fetal genotype is the same as the the β (and/or α) globin genes rapidly and accurately for maternal genotype. Fetal DNA analysis should also be all mutations. This aspect is being addressed by the performed in duplicate and confirmed by an independent development of arrays. Although in their infancy, the PCR-based technique. We did PND for 176 couples arrays hold great promise and are amenable to scaling up which had background of thalassemia in fi rst pregnancy. and automation. In the short term, the current generation Results of PND diagnosis in the first trimester showed of instruments such as the capillary electrophoresis 62 affected fetuses with β-thalassemia major and sickle systems, has greatly simplified DNA sequence analysis. cell disease which led to termination of the pregnancy. In
The capillary electrophoresis system also lends itself to ) .
